16-30711901-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006662.3(SRCAP):​c.1559G>A​(p.Ser520Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000889 in 1,613,902 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00094 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00088 ( 7 hom. )

Consequence

SRCAP
NM_006662.3 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.55

Publications

9 publications found
Variant links:
Genes affected
SRCAP (HGNC:16974): (Snf2 related CREBBP activator protein) This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]
SRCAP Gene-Disease associations (from GenCC):
  • developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Floating-Harbor syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007154882).
BP6
Variant 16-30711901-G-A is Benign according to our data. Variant chr16-30711901-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 218688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000884 (1292/1461766) while in subpopulation MID AF = 0.0146 (84/5768). AF 95% confidence interval is 0.0121. There are 7 homozygotes in GnomAdExome4. There are 676 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 143 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRCAPNM_006662.3 linkc.1559G>A p.Ser520Asn missense_variant Exon 12 of 34 ENST00000262518.9 NP_006653.2 Q6ZRS2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRCAPENST00000262518.9 linkc.1559G>A p.Ser520Asn missense_variant Exon 12 of 34 2 NM_006662.3 ENSP00000262518.4 Q6ZRS2-1
ENSG00000282034ENST00000380361.7 linkn.1502G>A non_coding_transcript_exon_variant Exon 9 of 31 2 ENSP00000369719.3 A0A0C4DFX4

Frequencies

GnomAD3 genomes
AF:
0.000941
AC:
143
AN:
152018
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.0112
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.000941
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00125
AC:
314
AN:
251278
AF XY:
0.00135
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.0110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000976
Gnomad OTH exome
AF:
0.00407
GnomAD4 exome
AF:
0.000884
AC:
1292
AN:
1461766
Hom.:
7
Cov.:
32
AF XY:
0.000930
AC XY:
676
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.000806
AC:
27
AN:
33480
American (AMR)
AF:
0.00170
AC:
76
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
293
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53296
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5768
European-Non Finnish (NFE)
AF:
0.000618
AC:
687
AN:
1112010
Other (OTH)
AF:
0.00177
AC:
107
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
82
164
246
328
410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000940
AC:
143
AN:
152136
Hom.:
0
Cov.:
32
AF XY:
0.000955
AC XY:
71
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41518
American (AMR)
AF:
0.00170
AC:
26
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0112
AC:
39
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.000941
AC:
64
AN:
67998
Other (OTH)
AF:
0.00238
AC:
5
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00145
Hom.:
6
Bravo
AF:
0.00104
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000807
AC:
98
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00191
EpiControl
AF:
0.00107

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SRCAP: BS1 -

Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
May 15, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 10, 2022
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
21
DANN
Benign
0.83
DEOGEN2
Benign
0.037
T;T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.046
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.68
T;T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.0072
T;T
MetaSVM
Uncertain
-0.10
T
MutationAssessor
Benign
0.90
L;.
PhyloP100
1.6
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.81
N;.
REVEL
Benign
0.24
Sift
Uncertain
0.020
D;.
Sift4G
Benign
0.22
T;T
Polyphen
0.0010
B;.
Vest4
0.19
MVP
0.26
MPC
0.50
ClinPred
0.0081
T
GERP RS
3.9
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.8
Varity_R
0.082
gMVP
0.12
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139339184; hg19: chr16-30723222; API